A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2023

Study Completion Date

July 31, 2027

Conditions
Breast Cancer
Trial Locations (27)

T2N 4N2

Tom Baker Cancer Centre, Calgary

V2S 0C2

Abbotsford Centre, Abbotsford

V2M 7E9

BC Cancer Agency, Centre for the North, Prince George

V5Z 4E6

BCCA - Vancouver Centre, Vancouver

V9R 6V5

BC Cancer Agency, Victoria

R3E 0V9

Cancer Care Manitoba, Winnipeg

L4M 6M2

Royal Victoria Regional Health Centre, Barrie

P3E 5J1

Northeastern Ontario Regional Cancer Centre, Greater Sudbury

L8V 1C3

Juravinski Cancer Centre, Hamilton

Unknown

Cancer Centre of Southern Ontario at Kingston, Kingston

N2G 1G3

Grand River Regional Cancer Centre, Kitchener

N6A 4L6

London Regional Cancer Centre, London

L1G 2B9

R.S. McLaughlin Durham Regional Cancer Centre, Oshawa

K1H 8L6

Ottawa Regional Cancer Centre, Ottawa

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

L2S 0A9

Niagara Health System, St. Catharines

P7B 6V4

Thunder Bay Regional Health Sciences, Thunder Bay

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 1Z6

Princess Margaret Cancer Centre, Toronto

H7M 3L9

Centre integre de sante et de services sociaux de laval (CISSS de Laval), Laval

H2L 4M1

CHUM - Hopital Notre Dame, Montreal

H3T1E2

The Jewish General Hospital, Montreal

H4A 3J1

McGill University Health Centre, Montreal

G1R 2J6

CHUQ - Pavillon Hotel-Dieu de Quebec, Québec

J1H 5N4

CHUS - Hopital Fleurimont, Sherbrooke

S4T 7T1

The Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

All Listed Sponsors
collaborator

British Columbia Cancer Agency

OTHER

lead

Ontario Clinical Oncology Group (OCOG)

OTHER